These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 1739287)
21. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis. Nassif A; Bensussan A; Dorothée G; Mami-Chouaib F; Bachot N; Bagot M; Boumsell L; Roujeau JC J Invest Dermatol; 2002 Apr; 118(4):728-33. PubMed ID: 11918724 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical studies of major histocompatibility antigens in a case of the bare lymphocyte syndrome without immunodeficiency. Watanabe S; Iwata M; Maeda H; Ishibashi Y J Am Acad Dermatol; 1987 Nov; 17(5 Pt 2):895-902. PubMed ID: 3680679 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of the potential role of cytokines in toxic epidermal necrolysis. Nassif A; Moslehi H; Le Gouvello S; Bagot M; Lyonnet L; Michel L; Boumsell L; Bensussan A; Roujeau JC J Invest Dermatol; 2004 Nov; 123(5):850-5. PubMed ID: 15482470 [TBL] [Abstract][Full Text] [Related]
24. Immunopathologic study of lichenoid skin diseases: correlation between HLA-DR-positive keratinocytes or Langerhans cells and epidermotropic T cells. Shiohara T; Moriya N; Tanaka Y; Arai Y; Hayakawa J; Chiba M; Nagashima M J Am Acad Dermatol; 1988 Jan; 18(1 Pt 1):67-74. PubMed ID: 2450110 [TBL] [Abstract][Full Text] [Related]
25. Immunohistologic evaluation of the effect of cyclosporine treatment on the lichen planus immune infiltrate. Mozzanica N; Cattaneo A; Legori A; Pigatto P; Finzi AF J Am Acad Dermatol; 1991 Apr; 24(4):550-4. PubMed ID: 2033128 [TBL] [Abstract][Full Text] [Related]
31. HLA-DR-positive keratinocytes are associated with suppressor lymphocyte epidermotropism. A biomathematical study. Smolle J; Soyer HP; Juettner FM; Torne R; Stettner H; Kerl H Am J Dermatopathol; 1988 Apr; 10(2):128-32. PubMed ID: 2467574 [TBL] [Abstract][Full Text] [Related]
32. Immunopathology of cutaneous human lupus erythematosus defined by murine monoclonal antibodies. Andrews BS; Schenk A; Barr R; Friou G; Mirick G; Ross P J Am Acad Dermatol; 1986 Sep; 15(3):474-81. PubMed ID: 3489741 [TBL] [Abstract][Full Text] [Related]
33. Expression of α-defensin 1-3 in T cells from severe cutaneous drug-induced hypersensitivity reactions. Morel E; Alvarez L; Cabañas R; Fiandor A; Díaz R; Escamochero S; Prior N; Blanca M; Bellón T Allergy; 2011 Mar; 66(3):360-7. PubMed ID: 20880148 [TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical study of graft-versus-host reaction (GVHR)-type drug eruptions. Osawa J; Kitamura K; Saito S; Ikezawa Z; Nakajima H J Dermatol; 1994 Jan; 21(1):25-30. PubMed ID: 7908910 [TBL] [Abstract][Full Text] [Related]
35. On quantification of CD1a, HLA-DR, and HLA class I expression on viable human Langerhans cells and keratinocytes. Sprogøe-Jakobsen U; Lillevang ST; Kristensen T Cytometry; 1997 Aug; 30(4):206-7. PubMed ID: 9298841 [No Abstract] [Full Text] [Related]
36. Normal human skin lymphocytic and Langerhans' cell responses to intradermal interferon alpha-2 beta injections. Tong Y; Tucker SB Am J Med Sci; 1993 Jul; 306(1):23-7. PubMed ID: 7687094 [TBL] [Abstract][Full Text] [Related]
37. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis. Chung WH; Hung SI Allergol Int; 2010 Dec; 59(4):325-32. PubMed ID: 20962567 [TBL] [Abstract][Full Text] [Related]
38. Effect of N-acetylcysteine combined with infliximab on toxic epidermal necrolysis. A proof-of-concept study. Paquet P; Jennes S; Rousseau AF; Libon F; Delvenne P; Piérard GE Burns; 2014 Dec; 40(8):1707-12. PubMed ID: 24726294 [TBL] [Abstract][Full Text] [Related]
40. Immunopathology of American cutaneous leishmaniasis. Modulation of MHC class II gene products by keratinocytes before and after glucantime therapy. Pirmez C; Oliveira-Neto MP; Grimaldi Júnior G; Savino W Mem Inst Oswaldo Cruz; 1990; 85(2):203-9. PubMed ID: 2128362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]